Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)

The purpose of this randomized trial was to evaluate the efficacy of combination chemoimmunotherapy compared with chemotherapy alone. A total of 124 patients were randomized to receive intravenous cisplatin (35 mg m(−2), days 1–3), carmustine (150 mg m(−2), day 1, cycles 1 and 3 only), dacarbacine (...

Descripción completa

Detalles Bibliográficos
Autores principales: Atzpodien, J, Neuber, K, Kamanabrou, D, Fluck, M, Bröcker, E B, Neumann, C, Rünger, T M, Schuler, G, von den Driesch, P, Müller, I, Paul, E, Patzelt, T, Reitz, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375173/
https://www.ncbi.nlm.nih.gov/pubmed/11870502
http://dx.doi.org/10.1038/sj.bjc.6600043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375173/
https://www.ncbi.nlm.nih.gov/pubmed/11870502
http://dx.doi.org/10.1038/sj.bjc.6600043

Ejemplares similares